List of largest pharmaceutical mergers and acquisitions

The following tabls list the top-9 largest mergers and acquisitions in the pharmaceutical and biotechnology indisutry. Transactions are given in the dollar value for the year of the merger as well as adjusted for inflation.

Rank Year Purchaser Target Value
(in billions USD)
Value
(adjusted for inflation)
Ref
1 1999 Pfizer Warner-Lambert 90.0 128 [1]
2 2000 Glaxo Wellcome Plc SmithKline Beecham Plc. 76.0 105
3 2004 Sanofi Aventis 73.5 92 [2]
4 2015 Actavis Allergan, Inc 70.5 71 [3][4][5]
5 2009 Pfizer Wyeth 68.0 75
6 2002 Pfizer Pharmacia 64.3 85 [2]
7 2009 Merck & Co. Schering-Plough 47.1 52 [6]
8 2014 Medtronic Covidien 42.3 42
9 2015 Teva Pharmaceutical Industries Actavis 40.5 41

Pfizer & Allergan

In November 2015 Pfizer announced it would acquire Allergan, Plc for $160 billion. However, this deal was cancelled in April 2016 due to new US tax inversion rules.[7][8] Had this transaction been completed, this would have been the largest within this industry.

See also

References

This article is issued from Wikipedia - version of the 6/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.